Skip to main content
Top
Published in: Endocrine 3/2018

01-03-2018 | Original Article

The computed tomography adrenal wash-out analysis properly classifies cortisol secreting adrenocortical adenomas

Authors: Anne-Laure Humbert, Guillaume Lecoanet, Sophie Moog, Fehd Bouderraoui, Laurent Bresler, Jean-Michel Vignaud, Elodie Chevalier, Laurent Brunaud, Marc Klein, Thomas Cuny

Published in: Endocrine | Issue 3/2018

Login to get access

Abstract

Purpose

Adrenocortical lesions are characterized through imaging, hormonal and histopathological analysis. Our aim was to compare the radiological features of adrenocortical lesions with their cortisol-secreting status and histopathological Weiss score.

Methods

Seventy five patients operated between 2004 and 2016 in the University Hospital of Nancy for either adrenocortical carcinomas (ACC) or adrenocortical adenomas (ACA) were enrolled in this study. We collected cortisol parameters, Computed Tomography (CT) scans (unenhanced density, wash-out (WO) analysis) and 18F-Fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) datas. The histopathological Weiss score ultimately differentiates ACA (score ≤ 2) from ACC (score ≥ 3). One-way ANOVA, Fisher’s exact and unpaired t tests were used for statistical analysis with significancy reached at p < 0.05.

Results

There were 23 ACC and 52 ACA with 40 patients (53%) who had an autonomous secretion of cortisol. On CT scan, ACC were larger compared to ACA (108 vs. 37 mm, p < 0.0001). A roughly similar proportion of cortisol-secreting (22/25) and non-secreting (15/19) ACA were atypical (i.e., unenhanced density value ≥ 10 Hounsfield Units [HU]), however 85% of cortisol-secreting vs. 40% of non-secreting ACA were classified as benigns by the relative WO analysis (p = 0.08). Likewise, there was a trend for a higher 18F-FDG uptake in cortisol-secreting ACA compared to non-secreting ACA (p = 0.053).

Conclusions

The relative adrenal WO analysis consolidates the benign nature of an ACA, especially in case of cortisol oversecretion, a condition known to compromise the diagnostic accuracy of the 10 HU unenhanced CT attenuation threshold.
Appendix
Available only for authorised users
Literature
1.
go back to reference J.H. Song, F.S. Chaudhry, W.W. Mayo-Smith, The incidental adrenal mass on CT: Prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. Am. J. Roentgenol. 190, 1163–1168 (2008)CrossRef J.H. Song, F.S. Chaudhry, W.W. Mayo-Smith, The incidental adrenal mass on CT: Prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. Am. J. Roentgenol. 190, 1163–1168 (2008)CrossRef
2.
go back to reference W.F. Young, Clinical practice. The incidentally discovered adrenal mass. N. Engl. J. Med. 356, 601–610 (2007). CrossRef W.F. Young, Clinical practice. The incidentally discovered adrenal mass. N. Engl. J. Med. 356, 601–610 (2007). CrossRef
3.
go back to reference M. Terzolo, A. Stigliano, I. Chiodini, P. Loli, L. Furlani, G. Arnaldi, G. Reimondo, A. Pia, V. Toscano, M. Zini, G. Borretta, E. Papini, P. Garofalo, B. Allolio, B. Dupas, F. Mantero, A. Tabarin, AME position statement on adrenal incidentaloma. Eur. J. Endocrinol. 164, 851–870 (2011)CrossRef M. Terzolo, A. Stigliano, I. Chiodini, P. Loli, L. Furlani, G. Arnaldi, G. Reimondo, A. Pia, V. Toscano, M. Zini, G. Borretta, E. Papini, P. Garofalo, B. Allolio, B. Dupas, F. Mantero, A. Tabarin, AME position statement on adrenal incidentaloma. Eur. J. Endocrinol. 164, 851–870 (2011)CrossRef
4.
go back to reference A. Frilling, K. Tecklenborg, F. Weber, H. Kühl, S. Müller, G. Stamatis, C. Broelsch, Importance of adrenal incidentaloma in patients with a history of malignancy. Surgery 136, 1289–1296 (2004)CrossRef A. Frilling, K. Tecklenborg, F. Weber, H. Kühl, S. Müller, G. Stamatis, C. Broelsch, Importance of adrenal incidentaloma in patients with a history of malignancy. Surgery 136, 1289–1296 (2004)CrossRef
5.
go back to reference M. Fassnacht, W. Arlt, I. Bancos, H. Dralle, J. Newell-Price, A. Sahdev, A. Tabarin, M. Terzolo, S. Tsagarakis, O.M. Dekkers, Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 175, G1–G34 (2016)CrossRef M. Fassnacht, W. Arlt, I. Bancos, H. Dralle, J. Newell-Price, A. Sahdev, A. Tabarin, M. Terzolo, S. Tsagarakis, O.M. Dekkers, Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 175, G1–G34 (2016)CrossRef
6.
go back to reference J.H. Song, D.J. Grand, M.D. Beland, K.J. Chang, J.T. Machan, W.W. Mayo-Smith, Morphologic features of 211 adrenal masses at initial contrast-enhanced CT: can we differentiate benign from malignant lesions using imaging features alone? Ajr. Am. J. Roentgenol. 201, 1248–1253 (2013)CrossRef J.H. Song, D.J. Grand, M.D. Beland, K.J. Chang, J.T. Machan, W.W. Mayo-Smith, Morphologic features of 211 adrenal masses at initial contrast-enhanced CT: can we differentiate benign from malignant lesions using imaging features alone? Ajr. Am. J. Roentgenol. 201, 1248–1253 (2013)CrossRef
7.
go back to reference A. Sahdev, J. Willatt, I.R. Francis, R.H. Reznek, The indeterminate adrenal lesion. Cancer Imaging 10, 102–113 (2010)CrossRef A. Sahdev, J. Willatt, I.R. Francis, R.H. Reznek, The indeterminate adrenal lesion. Cancer Imaging 10, 102–113 (2010)CrossRef
8.
go back to reference C. Chambre, E. McMurray, C. Baudry, M. Lataud, L. Guignat, S. Gaujoux, N. Lahlou, J. Guibourdenche, F. Tissier, M. Sibony, B. Dousset, X. Bertagna, J. Bertherat, P. Legmann, L. Groussin, The 10 Hounsfield units unenhanced computed tomography attenuation threshold does not apply to cortisol secreting adrenocortical adenomas. Eur. J. Endocrinol. 173, 325–332 (2015)CrossRef C. Chambre, E. McMurray, C. Baudry, M. Lataud, L. Guignat, S. Gaujoux, N. Lahlou, J. Guibourdenche, F. Tissier, M. Sibony, B. Dousset, X. Bertagna, J. Bertherat, P. Legmann, L. Groussin, The 10 Hounsfield units unenhanced computed tomography attenuation threshold does not apply to cortisol secreting adrenocortical adenomas. Eur. J. Endocrinol. 173, 325–332 (2015)CrossRef
9.
go back to reference M.A. Blake, M.K. Kalra, A.T. Sweeney, B.C. Lucey, M.M. Maher, D.V. Sahani, E.F. Halpern, P.R. Mueller, P.F. Hahn, G.W. Boland, Distinguishing Benign from Malignant Adrenal Masses: Multi–Detector Row CT Protocol with 10-Minute Delay 1. Radiology 238, 578–585 (2006)CrossRef M.A. Blake, M.K. Kalra, A.T. Sweeney, B.C. Lucey, M.M. Maher, D.V. Sahani, E.F. Halpern, P.R. Mueller, P.F. Hahn, G.W. Boland, Distinguishing Benign from Malignant Adrenal Masses: Multi–Detector Row CT Protocol with 10-Minute Delay 1. Radiology 238, 578–585 (2006)CrossRef
10.
go back to reference C.S. Peña, G.W. Boland, P.F. Hahn, M.J. Lee, P.R. Mueller, Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 217, 798–802 (2000)CrossRef C.S. Peña, G.W. Boland, P.F. Hahn, M.J. Lee, P.R. Mueller, Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 217, 798–802 (2000)CrossRef
11.
go back to reference L. Groussin, G. Bonardel, S. Silvéra, F. Tissier, J. Coste, G. Abiven, R. Libé, M. Bienvenu, J.-L. Alberini, S. Salenave, P. Bouchard, J. Bertherat, B. Dousset, P. Legmann, B. Richard, H. Foehrenbach, X. Bertagna, F. Tenenbaum, 18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients. J. Clin. Endocrinol. Metab. 94, 1713–1722 (2009)CrossRef L. Groussin, G. Bonardel, S. Silvéra, F. Tissier, J. Coste, G. Abiven, R. Libé, M. Bienvenu, J.-L. Alberini, S. Salenave, P. Bouchard, J. Bertherat, B. Dousset, P. Legmann, B. Richard, H. Foehrenbach, X. Bertagna, F. Tenenbaum, 18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients. J. Clin. Endocrinol. Metab. 94, 1713–1722 (2009)CrossRef
12.
go back to reference C. Guerin, F. Pattou, L. Brunaud, J.-C. Lifante, E. Mirallié, M. Haissaguerre, D. Huglo, P. Olivier, C. Houzard, C. Ansquer, E. Hindié, A. Loundou, C. Archange, A. Tabarin, F. Sebag, K. Baumstarck, D. Taïeb, Performance of 18F-FDG PET/CT in the characterization of adrenal masses in noncancer patients: a prospective study. J. Clin. Endocrinol. Metab. 102, 2465–2472 (2017)CrossRef C. Guerin, F. Pattou, L. Brunaud, J.-C. Lifante, E. Mirallié, M. Haissaguerre, D. Huglo, P. Olivier, C. Houzard, C. Ansquer, E. Hindié, A. Loundou, C. Archange, A. Tabarin, F. Sebag, K. Baumstarck, D. Taïeb, Performance of 18F-FDG PET/CT in the characterization of adrenal masses in noncancer patients: a prospective study. J. Clin. Endocrinol. Metab. 102, 2465–2472 (2017)CrossRef
13.
go back to reference G.W.L. Boland, B.A. Dwamena, M. Jagtiani Sangwaiya, A.G. Goehler, M.A. Blake, P.F. Hahn, J.A. Scott, M.K. Kalra, Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance. Radiology 259, 117–126 (2011)CrossRef G.W.L. Boland, B.A. Dwamena, M. Jagtiani Sangwaiya, A.G. Goehler, M.A. Blake, P.F. Hahn, J.A. Scott, M.K. Kalra, Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance. Radiology 259, 117–126 (2011)CrossRef
14.
go back to reference L.M. Weiss, Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am. J. Surg. Pathol. 8, 163–169 (1984)CrossRef L.M. Weiss, Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am. J. Surg. Pathol. 8, 163–169 (1984)CrossRef
15.
go back to reference M. Korobkin, T.J. Giordano, F.J. Brodeur, I.R. Francis, E.S. Siegelman, L.E. Quint, N.R. Dunnick, J.P. Heiken, H.H. Wang, Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology 200, 743–747 (1996)CrossRef M. Korobkin, T.J. Giordano, F.J. Brodeur, I.R. Francis, E.S. Siegelman, L.E. Quint, N.R. Dunnick, J.P. Heiken, H.H. Wang, Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology 200, 743–747 (1996)CrossRef
16.
go back to reference E.M. Caoili, M. Korobkin, I.R. Francis, R.H. Cohan, N.R. Dunnick, Delayed enhanced CT of lipid-poor adrenal adenomas. Am. J. Roentgenol. 175, 1411–1415 (2000)CrossRef E.M. Caoili, M. Korobkin, I.R. Francis, R.H. Cohan, N.R. Dunnick, Delayed enhanced CT of lipid-poor adrenal adenomas. Am. J. Roentgenol. 175, 1411–1415 (2000)CrossRef
17.
go back to reference B.K. Park, B. Kim, K. Ko, S.Y. Jeong, G.Y. Kwon, Adrenal masses falsely diagnosed as adenomas on unenhanced and delayed contrast-enhanced computed tomography: Pathological correlation. Eur. Radiol. 16, 642–647 (2006)CrossRef B.K. Park, B. Kim, K. Ko, S.Y. Jeong, G.Y. Kwon, Adrenal masses falsely diagnosed as adenomas on unenhanced and delayed contrast-enhanced computed tomography: Pathological correlation. Eur. Radiol. 16, 642–647 (2006)CrossRef
18.
go back to reference A. Kutikov, K. Mallin, D. Canter, Y.-N. Wong, R.G. Uzzo, Effects of increased cross sectional imaging on the diagnosis and prognosis of adrenocortical carcinoma: analysis of the national cancer data base. J. Urol. 186, 805–810 (2011)CrossRef A. Kutikov, K. Mallin, D. Canter, Y.-N. Wong, R.G. Uzzo, Effects of increased cross sectional imaging on the diagnosis and prognosis of adrenocortical carcinoma: analysis of the national cancer data base. J. Urol. 186, 805–810 (2011)CrossRef
19.
go back to reference T.M.A. Kerkhofs, R.H.A. Verhoeven, J.M. Van der Zwan, J. Dieleman, M.N. Kerstens, T.P. Links, L.V. Van, de Poll-Franse, H.R. Haak, Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993. Eur. J. Cancer 49, 2579–2586 (2013)CrossRef T.M.A. Kerkhofs, R.H.A. Verhoeven, J.M. Van der Zwan, J. Dieleman, M.N. Kerstens, T.P. Links, L.V. Van, de Poll-Franse, H.R. Haak, Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993. Eur. J. Cancer 49, 2579–2586 (2013)CrossRef
20.
go back to reference A.O. Ciftci, M.E. Şenocak, F.C. Tanyel, N. Büyükpamukçu, Adrenocortical tumors in children. J. Pediatr. Surg. 36, 549–554 (2001)CrossRef A.O. Ciftci, M.E. Şenocak, F.C. Tanyel, N. Büyükpamukçu, Adrenocortical tumors in children. J. Pediatr. Surg. 36, 549–554 (2001)CrossRef
21.
go back to reference T. Kerkhofs, M. Ettaieb, R. Verhoeven, G. Kaspers, W. Tissing, J. Loeffen, M. Van den Heuvel-Eibrink, R. De Krijger, H. Haak, Adrenocortical carcinoma in children: First population‑based clinicopathological study with long-term follow-up. Oncol. Rep. 32, 2836–2844 (2014)CrossRef T. Kerkhofs, M. Ettaieb, R. Verhoeven, G. Kaspers, W. Tissing, J. Loeffen, M. Van den Heuvel-Eibrink, R. De Krijger, H. Haak, Adrenocortical carcinoma in children: First population‑based clinicopathological study with long-term follow-up. Oncol. Rep. 32, 2836–2844 (2014)CrossRef
22.
go back to reference D. Patel, S.K. Gara, R.J. Ellis, M. Boufraqech, N. Nilubol, C. Millo, C.A. Stratakis, E. Kebebew, FDG PET/CT scan and Ffnctional adrenal tumors: a pilot study for lateralization. World J. Surg. 40, 683–689 (2016)CrossRef D. Patel, S.K. Gara, R.J. Ellis, M. Boufraqech, N. Nilubol, C. Millo, C.A. Stratakis, E. Kebebew, FDG PET/CT scan and Ffnctional adrenal tumors: a pilot study for lateralization. World J. Surg. 40, 683–689 (2016)CrossRef
23.
go back to reference N. Jin, W. Qian, X. Yin, L. Zhang, K. Iqbal, I. Grundke-Iqbal, C.-X. Gong, F. Liu, CREB regulates the expression of neuronal glucose transporter 3: a possible mechanism related to impaired brain glucose uptake in Alzheimer's disease. Nucleic Acids Res. 41, 3240–3256 (2013)CrossRef N. Jin, W. Qian, X. Yin, L. Zhang, K. Iqbal, I. Grundke-Iqbal, C.-X. Gong, F. Liu, CREB regulates the expression of neuronal glucose transporter 3: a possible mechanism related to impaired brain glucose uptake in Alzheimer's disease. Nucleic Acids Res. 41, 3240–3256 (2013)CrossRef
24.
go back to reference F. Beuschlein, M. Fassnacht, G. Assié, D. Calebiro, C.A. Stratakis, A. Osswald, C.L. Ronchi, T. Wieland, S. Sbiera, F.R. Faucz, K. Schaak, A. Schmittfull, T. Schwarzmayr, O. Barreau, D. Vezzosi, M. Rizk-Rabin, U. Zabel, E. Szarek, P. Salpea, A. Forlino, A. Vetro, O. Zuffardi, C. Kisker, S. Diener, T. Meitinger, M.J. Lohse, M. Reincke, J. Bertherat, T.M. Strom, B. Allolio, Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome. N. Engl. J. Med. 370, 1019–1028 (2014)CrossRef F. Beuschlein, M. Fassnacht, G. Assié, D. Calebiro, C.A. Stratakis, A. Osswald, C.L. Ronchi, T. Wieland, S. Sbiera, F.R. Faucz, K. Schaak, A. Schmittfull, T. Schwarzmayr, O. Barreau, D. Vezzosi, M. Rizk-Rabin, U. Zabel, E. Szarek, P. Salpea, A. Forlino, A. Vetro, O. Zuffardi, C. Kisker, S. Diener, T. Meitinger, M.J. Lohse, M. Reincke, J. Bertherat, T.M. Strom, B. Allolio, Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome. N. Engl. J. Med. 370, 1019–1028 (2014)CrossRef
25.
go back to reference D. Calebiro, G. Di Dalmazi, K. Bathon, C.L. Ronchi, F. Beuschlein, cAMP signaling in cortisol-producing adrenal adenoma. Eur. J. Endocrinol. 173, M99–M106 (2015)CrossRef D. Calebiro, G. Di Dalmazi, K. Bathon, C.L. Ronchi, F. Beuschlein, cAMP signaling in cortisol-producing adrenal adenoma. Eur. J. Endocrinol. 173, M99–M106 (2015)CrossRef
26.
go back to reference G. Di Dalmazi, R. Pasquali, F. Beuschlein, M. Reincke, Subclinical hypercortisolism: a state, a syndrome, or a disease? Eur. J. Endocrinol. 173, M61–M71 (2015)CrossRef G. Di Dalmazi, R. Pasquali, F. Beuschlein, M. Reincke, Subclinical hypercortisolism: a state, a syndrome, or a disease? Eur. J. Endocrinol. 173, M61–M71 (2015)CrossRef
Metadata
Title
The computed tomography adrenal wash-out analysis properly classifies cortisol secreting adrenocortical adenomas
Authors
Anne-Laure Humbert
Guillaume Lecoanet
Sophie Moog
Fehd Bouderraoui
Laurent Bresler
Jean-Michel Vignaud
Elodie Chevalier
Laurent Brunaud
Marc Klein
Thomas Cuny
Publication date
01-03-2018
Publisher
Springer US
Published in
Endocrine / Issue 3/2018
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-018-1522-7

Other articles of this Issue 3/2018

Endocrine 3/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine